Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?
1
Hematology Section, Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, 4650 Sunset boulevard, Los Angeles, CA 90027, USA
2
Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA 90089, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(10), 1690; https://doi.org/10.3390/jcm8101690
Received: 29 August 2019 / Revised: 11 October 2019 / Accepted: 11 October 2019 / Published: 15 October 2019
(This article belongs to the Special Issue Sickle Cell Anemia: From Genetic Epidemiology to New Therapeutic Strategies)
Sickle cell disease (SCD) is an inherited hemoglobinopathy characterized by polymerization of hemoglobin S upon deoxygenation that results in the formation of rigid sickled-shaped red blood cells that can occlude the microvasculature, which leads to sudden onsets of pain. The severity of vaso-occlusive crises (VOC) is quite variable among patients, which is not fully explained by their genetic and biological profiles. The mechanism that initiates the transition from steady state to VOC remains unknown, as is the role of clinically reported triggers such as stress, cold and pain. The rate of hemoglobin S polymerization after deoxygenation is an important determinant of vaso-occlusion. Similarly, the microvascular blood flow rate plays a critical role as fast-moving red blood cells are better able to escape the microvasculature before polymerization of deoxy-hemoglobin S causes the red cells to become rigid and lodge in small vessels. The role of the autonomic nervous system (ANS) activity in VOC initiation and propagation has been underestimated considering that the ANS is the major regulator of microvascular blood flow and that most triggers of VOC can alter the autonomic balance. Here, we will briefly review the evidence supporting the presence of ANS dysfunction in SCD, its implications in the onset of VOC, and how differences in autonomic vasoreactivity might potentially contribute to variability in VOC severity.
View Full-Text
Keywords:
sickle cell disease; autonomic nervous system dysfunction; vaso-occlusive crisis; pain; microvascular blood flow
▼
Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Veluswamy, S.; Shah, P.; Denton, C.C.; Chalacheva, P.; Khoo, M.C.K.; Coates, T.D. Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger? J. Clin. Med. 2019, 8, 1690.
AMA Style
Veluswamy S, Shah P, Denton CC, Chalacheva P, Khoo MCK, Coates TD. Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger? Journal of Clinical Medicine. 2019; 8(10):1690.
Chicago/Turabian StyleVeluswamy, Saranya; Shah, Payal; Denton, Christopher C.; Chalacheva, Patjanaporn; Khoo, Michael C.K.; Coates, Thomas D. 2019. "Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?" J. Clin. Med. 8, no. 10: 1690.
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit